These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22819085)

  • 21. [Early recognition of rheumatoid arthritis].
    van der Helm-van Mil AH; Posthumus MD
    Ned Tijdschr Geneeskd; 2011; 155(30-31):A2902. PubMed ID: 22085506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Nijmegen inception cohort of early rheumatoid arthritis.
    Welsing PM; van Riel PL
    J Rheumatol Suppl; 2004 Mar; 69():14-21. PubMed ID: 15053447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progression in early rheumatoid arthritis.
    Combe B
    Best Pract Res Clin Rheumatol; 2009 Feb; 23(1):59-69. PubMed ID: 19233046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in treat-to-target in patients with rheumatoid arthritis versus hypertension and diabetes--consequences for clinical care.
    Castrejón I; Pincus T
    Bull NYU Hosp Jt Dis; 2011; 69(2):104-10. PubMed ID: 22035388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of established rheumatoid arthritis with an emphasis on pharmacotherapy.
    Blom M; van Riel PL
    Best Pract Res Clin Rheumatol; 2007 Feb; 21(1):43-57. PubMed ID: 17350543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug management of early rheumatoid arthritis - 2008.
    Sokka T; Mäkinen H
    Best Pract Res Clin Rheumatol; 2009 Feb; 23(1):93-102. PubMed ID: 19233049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment and management of rheumatoid arthritis.
    Haraoui B
    J Rheumatol Suppl; 2009 Jun; 82():2-10. PubMed ID: 19509324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prevalence of clinical remission in RA patients treated with anti-TNF: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry.
    de Punder YM; Fransen J; Kievit W; Houtman PM; Visser H; van de Laar MA; van Riel PL
    Rheumatology (Oxford); 2012 Sep; 51(9):1610-7. PubMed ID: 22539487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rheumatoid arthritis treatment and monitoring of outcomes--where are we [corrected] in 2007?
    Yazici Y; Abramson SB
    Bull NYU Hosp Jt Dis; 2007; 65(4):300-5. PubMed ID: 18081549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measures of rheumatoid arthritis disease activity.
    Kirwan J
    J Rheumatol; 2009 Feb; 36(2):442-3; author reply 443-4. PubMed ID: 19208571
    [No Abstract]   [Full Text] [Related]  

  • 31. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with early rheumatoid arthritis.
    Fiedorczyk M; Klimiuk PA; Sierakowski S; Gindzienska-Sieskiewicz E; Chwiecko J
    J Rheumatol; 2006 Aug; 33(8):1523-9. PubMed ID: 16881109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identifying patient-reported outcomes in rheumatoid arthritis: the impact of foot symptoms on self-perceived quality of life.
    Otter SJ; Lucas K; Springett K; Moore A; Davies K; Young A; Walker-Bone K
    Musculoskeletal Care; 2012 Jun; 10(2):65-75. PubMed ID: 22337478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical relevance of a prediction rule for disease outcome in patients with undifferentiated arthritis: comment on the article by van der Helm-van Mil et al.
    Visser H; Hazes JM; Luime J
    Arthritis Rheum; 2009 Jul; 60(7):2208-9; author reply 2209-10. PubMed ID: 19565508
    [No Abstract]   [Full Text] [Related]  

  • 34. Early rheumatoid arthritis -- is there a window of opportunity?
    Cush JJ
    J Rheumatol Suppl; 2007 Nov; 80():1-7. PubMed ID: 17985417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What is the outcome of RA in 2011 and can we predict it?
    Verstappen SM; Symmons DP
    Best Pract Res Clin Rheumatol; 2011 Aug; 25(4):485-96. PubMed ID: 22137919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A tool to identify recent or present rheumatoid arthritis flare from both patient and physician perspectives: the 'FLARE' instrument.
    Berthelot JM; De Bandt M; Morel J; Benatig F; Constantin A; Gaudin P; Le Loet X; Maillefert JF; Meyer O; Pham T; Saraux A; Solau-Gervais E; Spitz E; Wendling D; Fautrel B; Guillemin F;
    Ann Rheum Dis; 2012 Jul; 71(7):1110-6. PubMed ID: 22072015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term outcome after anti-tumor necrosis factor-alpha therapy in rheumatoid arthritis: do we need to revise our assessment criteria?
    El Miedany Y; Youssef SS; El Gaafary M
    J Rheumatol; 2006 Mar; 33(3):490-7. PubMed ID: 16511918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of cutpoints for acceptable health status and important improvement in patient-reported outcomes, in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
    Kvamme MK; Kristiansen IS; Lie E; Kvien TK
    J Rheumatol; 2010 Jan; 37(1):26-31. PubMed ID: 19955045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial. Leflunomide Rheumatoid Arthritis Investigators Group.
    Tugwell P; Wells G; Strand V; Maetzel A; Bombardier C; Crawford B; Dorrier C; Thompson A
    Arthritis Rheum; 2000 Mar; 43(3):506-14. PubMed ID: 10728742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Simplified Disease Activity Index (SDAI) and Clinical Disease Activity Index (CDAI) to monitor patients in standard clinical care.
    Aletaha D; Smolen JS
    Best Pract Res Clin Rheumatol; 2007 Aug; 21(4):663-75. PubMed ID: 17678828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.